% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Hendriks:830498, author = {Hendriks, Christine M. M. and Hartkamp, Jörg and Wiezorek, Stefan and Steinkamp, Anne-Dorothee and Rossetti, Giulia and Lüscher, Bernhard and Bolm, Carsten}, title = {{S}ulfoximines as {ATR} inhibitors: {A}nalogs of {VE}-821}, journal = {Bioorganic $\&$ medicinal chemistry letters}, volume = {27}, number = {12}, issn = {0960-894X}, address = {Amsterdam [u.a.]}, publisher = {Elsevier Science}, reportid = {FZJ-2017-04039}, pages = {2659 - 2662}, year = {2017}, abstract = {The ATM- and Rad3-related (ATR) kinases play a key role in DNA repair processes and thus ATR is an attractive target for cancer therapy. Here we designed and synthesized sulfilimidoyl- and sulfoximidoyl-substituted analogs of the sulfone VE-821, a reported ATR inhibitor. The properties of these analogs have been investigated by calculating physicochemical parameters and studying their potential to specifically inhibit ATR in cells. Prolonged inhibition of ATR by the analogs in a Burkitt lymphoma cell line resulted in enhanced DNA damage and a substantial amount of apoptosis. Together our findings suggest that the sulfilimidoyl- and sulfoximidoyl-substituted analogs are efficient ATR inhibitors.}, cin = {IAS-5 / JSC / INM-9}, ddc = {540}, cid = {I:(DE-Juel1)IAS-5-20120330 / I:(DE-Juel1)JSC-20090406 / I:(DE-Juel1)INM-9-20140121}, pnm = {572 - (Dys-)function and Plasticity (POF3-572) / 511 - Computational Science and Mathematical Methods (POF3-511)}, pid = {G:(DE-HGF)POF3-572 / G:(DE-HGF)POF3-511}, typ = {PUB:(DE-HGF)16}, UT = {WOS:000402472600004}, doi = {10.1016/j.bmcl.2017.04.026}, url = {https://juser.fz-juelich.de/record/830498}, }